Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "South-Asia"

86 News Found

Strand Life launches advanced proteomics capabilities
Biopharma | May 19, 2026

Strand Life launches advanced proteomics capabilities

The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample


Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC
People | May 13, 2026

Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC

Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets


OBESITAS 2026 concludes with focus on India’s rising obesity burden
Healthcare | May 05, 2026

OBESITAS 2026 concludes with focus on India’s rising obesity burden

The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges


Nihon Kohden launches Life Scope E7 patient monitoring platform in India
Medical Device | April 15, 2026

Nihon Kohden launches Life Scope E7 patient monitoring platform in India

CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM


Apollo Hospitals Chennai performs India’s first adaptive deep brain stimulation for Parkinson’s
Hospitals | April 11, 2026

Apollo Hospitals Chennai performs India’s first adaptive deep brain stimulation for Parkinson’s

Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply


Bayer sets world record for maternal nutrition advocacy
Healthcare | April 09, 2026

Bayer sets world record for maternal nutrition advocacy

India continues to face a major maternal nutrition challenge, with nearly 60% of women affected by anaemia and more than 70% experiencing calcium deficiency


Bayer plans to offer Eylea 2mg at lower cost in India for benefit of retinal disease patients
News | April 02, 2026

Bayer plans to offer Eylea 2mg at lower cost in India for benefit of retinal disease patients

Eylea 2mg (intravitreal aflibercept injection) is an anti-VEGF therapy that blocks a protein responsible for abnormal blood vessel growth and leakage in the retina


Bayer introduces chemo-free treatment option for advanced prostate cancer in India
News | February 24, 2026

Bayer introduces chemo-free treatment option for advanced prostate cancer in India

Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year


Care ADHD opens its first Global Capability Centre in India
Healthcare | December 22, 2025

Care ADHD opens its first Global Capability Centre in India

UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country


Glenmark secures exclusive multi-regional rights to Aumolertinib from Hansoh Pharma
News | December 17, 2025

Glenmark secures exclusive multi-regional rights to Aumolertinib from Hansoh Pharma

Hansoh Pharma will receive an upfront payment in the low double-digit millions